Cargando…

Lack of involvement of lipocortin 1 in dexamethasone suppression of IL-1 release

The annexin lipocortin 1 is reported to mediate some anti-inflammatory effects of glucocorticoids, but the mechanisms of this mediation are incompletely understood. The involvement of lipocortin 1 in glucocorticoid inhibition of monocyte interleukin 1β (IL-1β) release has been investigated. Treatmen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Morand, E. F., Rickard, D., Goulding, N. J.
Formato:	Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 1993
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2365384/ https://www.ncbi.nlm.nih.gov/pubmed/18475502 http://dx.doi.org/10.1155/S0962935193000067

Ejemplares similares

Expression of lipocortins in human bronchial epithelial cells: effects of IL-1β , TNF-α, LPS and dexamethasone
por: Verheggen, M. M., et al.
Publicado: (1996)

The effect of lipocortin 1 on neutrophil deformability
por: Drost, E. M., et al.
Publicado: (1996)

Detection of lipocortin 1 in human lung lavage fluid: lipocortin degradation as a possible proteolytic mechanism in the control of inflammatory mediators and inflammation.
por: Smith, S F, et al.
Publicado: (1990)

Reduction of nitric oxide release from alveolar macrophages by a lipocortin peptide.
por: Kamal, A M, et al.
Publicado: (1998)

Conceivable difference in the anti-inflammatory mechanisms of lipocortins 1 and 5
por: Becherucci, C., et al.
Publicado: (1993)

Lipocortin-1 is an endogenous inhibitor of ischemic damage in the rat brain
Publicado: (1991)

The Effect of Steroid Treatment on Lipocortin Immunoreactivity of Rat Brain
por: Go, K. G., et al.
Publicado: (1994)

Inhibition of smooth muscle contraction and platelet aggregation by peptide 204–212 of lipocortin 5: an attempt to define some structure requirements
por: Mugridge, K. G., et al.
Publicado: (1993)

Elevated expression of annexin II (lipocortin II, p36) in a multidrug resistant small cell lung cancer cell line.
por: Cole, S. P., et al.
Publicado: (1992)

Dexamethasone: Lack of efficacy: case report
Publicado: (2020)

Dexamethasone: Lack of efficacy: 2 case reports
Publicado: (2021)

Antituberculars/dexamethasone: Lack of efficacy: case report
Publicado: (2021)

Dexamethasone/etoposide: Lack of efficacy: case report
Publicado: (2022)

Dexamethasone: Lack of efficacy: 4 case reports
Publicado: (2022)

Immune suppressive function of IL-1α release in the tumor microenvironment regulated by calpain 1
por: Lin, Dandan, et al.
Publicado: (2022)

PMON98 High-dose dexamethasone suppression test in ACTH-dependent Cushing's syndrome: Lessons learned on the lack of cortisol suppression
por: Ali, Roshaneh, et al.
Publicado: (2022)

Cromoglycate drugs suppress eicosanoid generation in U937 cells by promoting the release of Anx-A1
por: Yazid, Samia, et al.
Publicado: (2009)

Association between posttest dexamethasone and cortisol concentrations in the 1 mg overnight dexamethasone suppression test
por: Åsvold, Bjørn O, et al.
Publicado: (2012)

Antibacterials/dexamethasone/remdesivir: Lack of efficacy: case report
Publicado: (2022)

Anakinra/dexamethasone/etoposide: Lack of efficacy: case report
Publicado: (2021)

Dexamethasone/remdesivir/tocilizumab: Lack of efficacy: case report
Publicado: (2022)

Tissue‐resident macrophages actively suppress IL‐1beta release via a reactive prostanoid/IL‐10 pathway
por: Ipseiz, Natacha, et al.
Publicado: (2020)

Release of IL-1β Triggered by Milan Summer PM(10): Molecular Pathways Involved in the Cytokine Release
por: Bengalli, Rossella, et al.
Publicado: (2013)

Docosahexaenoic Acid Suppresses Silica-Induced Inflammasome Activation and IL-1 Cytokine Release by Interfering With Priming Signal
por: Wierenga, Kathryn A., et al.
Publicado: (2019)

ADRENOCORTICAL DYSFUNCTION IN DEPRESSION: RESPONSE TO DEXAMETHASONE SUPPRESSION TEST - A COMPARATIVE STUDY1
por: Gurnani, K.C., et al.
Publicado: (1988)

SAT-372 Correlation of Serum Dexamethasone and Cortisol Concentrations Post Dexamethasone 1 Mg in the Overnight Dexamethasone Suppression Test in Patients with Unilateral and Bilateral Adrenal Incidentalomas
por: Naseem, Asma, et al.
Publicado: (2019)

Dexamethasone/eltrombopag/methylprednisolone: Lack of efficacy: 2 case reports
Publicado: (2022)

Dexamethasone: Lack of efficacy and off-label use: case report
Publicado: (2022)

Dexamethasone/remdesivir: Lack of efficacy and drug withdrawal: case report
Publicado: (2022)

Dexamethasone: Lack of efficacy and off-label use: case report
Publicado: (2022)

Dexamethasone: Lack of efficacy and off-label use: case report
Publicado: (2022)

Infographic: Slow-release dexamethasone in proliferative vitreoretinopathy (PVR)
por: Mostafa, I., et al.
Publicado: (2021)

FRI172 Assessment Of Plasma Dexamethasone Levels After 1-mg Dexamethasone Suppression Test In Adults With Obesity
por: Paopongpaiboon, Pimonrat, et al.
Publicado: (2023)

Annexin I and dexamethasone effects on phospholipase and cyclooxygenase activity in human synoviocytes.
por: Sampey, A V, et al.
Publicado: (2000)

IL-1beta differently involved in IL-8 and FGF-2 release in crystalline silica-treated lung cell co-cultures
por: Herseth, Jan I, et al.
Publicado: (2008)

Analysis of serum interleukin(IL)‐1α, IL‐1β and IL‐18 in patients with systemic sclerosis
por: Lin, Emily, et al.
Publicado: (2019)

DEXAMETHASONE SUPPRESSION TEST IN DEPRESSION
por: Reddy, M. Saikumar, et al.
Publicado: (1986)

DEXAMETHASONE SUPPRESSION TEST FOR MAJOR DEPRESSION
por: Ghulam, R., et al.
Publicado: (1985)

Bortezomib/dexamethasone/oxytetracycline: Chalazia, blepharitis and lack of efficacy: case report
Publicado: (2021)

Dexamethasone/remdesivir: Lack of efficacy and off-label use: case report
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jmoaq4ccmnt6j523eit5k2kbpg